Sigma-Aldrich's EPS (Basic) for the
three
months ended in Sep. 2015 was €0.85.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2015 was €3.61.
During the past 12 months, Sigma-Aldrich's average EPS without NRIGrowth Rate was -1.70% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 3.90% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 8.30% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 10.10% per year.
During the past 13 years, Sigma-Aldrich's highest 3-Year average EPS without NRI Growth Rate was 20.00% per year. The lowest was -0.20% per year. And the median was 11.90% per year.
Sigma-Aldrich Earnings per Share (Diluted) Historical Data
The historical data trend for Sigma-Aldrich's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sigma-Aldrich's Earnings per Share (Diluted)
For the Specialty Chemicals subindustry, Sigma-Aldrich's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sigma-Aldrich's PE Ratio Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Sigma-Aldrich's PE Ratio distribution charts can be found below:
* The bar in red indicates where Sigma-Aldrich's PE Ratio falls into.
Sigma-Aldrich Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Sigma-Aldrich's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2014 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.57
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
Sigma-Aldrich (FRA:SIQ) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Sigma-Aldrich Earnings per Share (Diluted) Related Terms
Thank you for viewing the detailed overview of Sigma-Aldrich's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Sigma-Aldrich Corp was incorporated under the laws of the State of Delaware in May 1975. The Company is a life science and a technology company that helps in enhancing human health and safety. The Company manufactures and distributes chemicals, biochemicals and other essential products and equipment products to its customers in research and applied labs as well as in industrial and commercial markets. The Company operates in three units including Research, Applied and SAFC Commercial. The Research unit products and services includes chemicals, reagents and kits, enabling the scientists to discover and develop new drugs and materials; Applied unit products and services includes high quality components and kits, chemical reagents, critical raw materials and certified reference standards, providing customized solutions to and constitute critical components and materials for diagnostic companies, testing laboratories and industrial companies; SAFC Commercial unit's products and services are used by its customers to develop and manufacture pharma, biopharma and electronics products. Its customers include pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies and hospitals. The Company's trademarks are the brand names; Sigma-Aldrich, Sigma, Aldrich, Fluka, Riedel-de Haën, Supelco, SAFC, SAFC Biosciences, SAFC Hitech, Genosys, Proligo, Pharmorphix, Cerilliant, Vetec, BioReliance and Cell Marque. The Company is subject to extensive regulation by federal, state and local governments and similar international agencies relating to the manufacture, sale and distribution of its products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:SIQ has been successfully added to your 